Venus Remedies (India)

Recent papers from Venus Remedies (India)

1. Sex-specific associations between psychological resilience and blastocyst qualityReproduction and Fertility · 2026
2. Media temperature control: a potentially important quality control parameter in human oocyte vitrificationReproduction and Fertility · 2026
3. Insecticides residues, physicochemical properties, antioxidant activity of Apis mellifera citrus honey from AlgeriaJournal of Apicultural Research · 2026
4. P103 VRP-034 at higher doses: a comprehensive preclinical evaluation of polymyxin B-associated nephrotoxicity across in vitro , in vivo and translational modelsJAC-Antimicrobial Resistance · 2025
5. P102 Influence of extracellular zinc on MBL activity and carbapenem susceptibilityJAC-Antimicrobial Resistance · 2025
6. Evaluating nephrotoxicity reduction in a novel polymyxin B formulation: insights from a 3D kidney-on-a-chip modelAntimicrobial Agents and Chemotherapy · 2024
7. Toxic Epidermal Necrolysis: A Case Report to Oral AcyclovirJournal of Drug Delivery and Therapeutics · 2024
8. Laparoscopic surgical correction of endometriosis improves fertility rates in infertile patients: a retrospective analysis of 119 casesInternational Journal of Reproduction Contraception Obstetrics and Gynecology · 2024
9. Meningitis-Retention Syndrome as an Unrecognized Clinical Condition in Indian Scenario: Fall Through the CracksCureus · 2024
10. Virtual Tour: Exploration of Perceptions and Acceptance by The CommunitiesJurnal Pariwisata Terapan · 2024
11. A survival case of high-dose amlodipine intoxication with non-cardiogenic pulmonary edema: a case reportAnnals of Medicine and Surgery · 2024
12. Lidocaine-induced anaphylactic shock – A case reportIndian Journal of Clinical Anaesthesia · 2023
13. A Case Study – Surgical Site Infection of Open Fracture Grade II Caused by Pseudomonas aeruginosaSAS Journal of Surgery · 2023
14. Bioequivalence of a biosimilar enoxaparin ( Cloti‐Xa™ ) and its innovator (Clexane®): A single‐dose , randomized, double‐blind , two‐period , two‐treatment , two‐sequence , crossover, balanced study in healthy human subjectsPharmacology Research & Perspectives · 2022
15. P06 Pharmacokinetics and renal accumulation of VRP-034JAC-Antimicrobial Resistance · 2022
16. P07 Toxicokinetic profile of VRP-034JAC-Antimicrobial Resistance · 2022
17. P05 In vivo efficacy of VRP-034 in lung and thigh infection modelsJAC-Antimicrobial Resistance · 2022
18. Functionalized non-woven surfaces for combating the spread of the COVID-19 pandemicInterface Focus · 2021
19. CAVA (Ultrasound‐Accelerated Catheter‐Directed Thrombolysis on Preventing Post‐Thrombotic Syndrome) Trial: Long‐Term Follow‐Up ResultsSHILAP Revista de lepidopterología · 2021
20. Polymyxin B-Induced Kidney Injury Assessment of a Novel Formulation of Polymyxin B (VRP-034) in RatsAntibiotics · 2021